Cargando…
Switching the Inhibitor‐Enzyme Recognition Profile via Chimeric Carbonic Anhydrase XII
A key part of the optimization of small molecules in pharmaceutical inhibitor development is to vary the molecular design to enhance complementarity of chemical features of the compound with the positioning of amino acids in the active site of a target enzyme. Typically this involves iterations of s...
Autores principales: | Smirnovienė, Joana, Smirnov, Alexey, Zakšauskas, Audrius, Zubrienė, Asta, Petrauskas, Vytautas, Mickevičiūtė, Aurelija, Michailovienė, Vilma, Čapkauskaitė, Edita, Manakova, Elena, Gražulis, Saulius, Baranauskienė, Lina, Chen, Wen‐Yih, Ladbury, John E., Matulis, Daumantas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095314/ https://www.ncbi.nlm.nih.gov/pubmed/33945229 http://dx.doi.org/10.1002/open.202100042 |
Ejemplares similares
-
Intrinsic Thermodynamics and Structure Correlation of Benzenesulfonamides with a Pyrimidine Moiety Binding to Carbonic Anhydrases I, II, VII, XII, and XIII
por: Kišonaitė, Miglė, et al.
Publicado: (2014) -
Beta and Gamma Amino Acid-Substituted Benzenesulfonamides as Inhibitors of Human Carbonic Anhydrases
por: Balandis, Benas, et al.
Publicado: (2022) -
PLBD: protein–ligand binding database of thermodynamic and kinetic intrinsic parameters
por: Lingė, Darius, et al.
Publicado: (2023) -
Crystal structure correlations with the intrinsic thermodynamics of human carbonic anhydrase inhibitor binding
por: Smirnov, Alexey, et al.
Publicado: (2018) -
Thiazide and other Cl-benzenesulfonamide-bearing clinical drug affinities for human carbonic anhydrases
por: Baranauskiene, Lina, et al.
Publicado: (2021)